NCT00194064 Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Status TERMINATED Phase PHASE3
NCT00191997 Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode Status COMPLETED Phase PHASE4
NCT00191828 A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme Status COMPLETED Phase PHASE4
NCT00191555 Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment Status COMPLETED Phase PHASE4
NCT00191399 Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response Status COMPLETED Phase PHASE4
NCT00190892 Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania Status COMPLETED Phase PHASE4
NCT00190749 Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00188942 A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder Status COMPLETED Phase PHASE4
NCT00183625 Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients Status COMPLETED Phase PHASE4
NCT00183612 Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents Status TERMINATED Phase NA
NCT00183404 Long-Term Olanzapine Treatment in Children With Autism Status COMPLETED Phase PHASE2/PHASE3
NCT00182507 Olanzapine in the Treatment of Hair Pulling (Trichotillomania) Status COMPLETED Phase PHASE4
NCT00182013 Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder Status COMPLETED Phase PHASE4
NCT00177567 Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study Status COMPLETED Phase PHASE4
NCT00174265 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) Status COMPLETED Phase PHASE3
NCT00169065 Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia Status COMPLETED Phase PHASE4
NCT00159796 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009) Status COMPLETED Phase PHASE3
NCT00159783 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) Status COMPLETED Phase PHASE3
NCT00159744 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) Status COMPLETED Phase PHASE3
NCT00156117 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) Status COMPLETED Phase PHASE3